Resources

Results 801 - 825 of 1414

Accredited Drug Seller Initiatives Publication Compendium: 2009–2017 [1]

MSH authors have published a number of journal articles describing the accredited drug seller implementation experience and lessons learned in Tanzania—home of the flagship ADDO program. A new compendium reviews highlights ranging from robust multi-method quantitative to informative qualitative research.

Quality IPTp Checklist for Facility Officers in Charge [3]

Due to its link to various complications during and after pregnancy, the prevention of malaria among pregnant women is regarded as an important strategy for reducing mortality and adverse maternal and neonatal health outcomes, such as maternal anemia, low birth weight, and perinatal deaths.

Malaria in pregnancy: Improving access and use of quality preventive treatment [5]

Due to its link to various complications during and after pregnancy, the prevention of malaria among pregnant women is an important strategy for reducing mortality and adverse maternal and neonatal health outcomes, such as anemia, low birth weight, and newborn death.

Gender Transformative Supportive Supervision Framework and Technical Brief [6]

This conceptual framework was designed to show the influence gender has on supervisor-provider relationships, and how this influence could be explored and addressed through programming and research.

Leaders Who Govern: Companion Guide [8]

This guide was developed as an abbreviated companion to the longer Management Sciences for Health publication Leaders Who Govern, with two main goals: To facilitate finding practical information about specific aspects of good governance

Pre-service Integration Guide [10]

The Pre-service Integration Guide is designed to assist heads of departments and faculty in pre-service health training institutions that train medical, nursing, pharmacy, laboratory and other allied health professionals to successfully introduce practical and action-oriented leadership and management modules into pre-service curricula for their students.

Network Strengthening Program (NSP) [12]

The objective of the NSP is to improve network effectiveness to meet their member’s needs and enhance their long-term sustainability. The content of the program includes: membership and benefits, distributed leadership, network governance, financial systems and sustainability, and communications for resource mobilization.

Ready Together Conference Program [14]

A Conference on Epidemic Preparedness November 13, 2017 The Joseph B. Martin Conference Center I Harvard Medical School

Methods Used in Prevalence Studies of Disrespect and Abuse during Facility Based Childbirth: Lessons Learned [15]

Several recent studies have attempted to measure the prevalence of disrespect and abuse (D&A) of women during childbirth in health facilities. Variations in reported prevalence may be associated with differences in study instruments and data collection methods. This systematic review and comparative analysis of methods aims to aggregate and present lessons learned from published studies that quantified the prevalence of D&A during childbirth.

Applying a New Framework for Public Health Systems Recovery Following Emergencies and Disasters: The Example of Haiti Following a Major Earthquake and Cholera Outbreak [16]

Emergencies can often directly impact health systems of an affected region or country, especially in resource-constrained areas. Health system recovery following an emergency is a complex and dynamic process. Health system recovery efforts have often been structured around the World Health Organization’s health systems building blocks as demonstrated by the Post-Disaster Needs Assessment. Although this structure is valuable and well known, it can overlook the intricacies of public health systems. We retrospectively examine public health systems recovery, a subset of the larger health system, following the 2010 Haiti earthquake and cholera outbreak, through the lens of the 10 essential public health services. This framework illustrates the comprehensive nature of and helps categorize the activities necessary for a well-functioning public health system and can complement other assessments. Outlining the features of a public health system for recovery in structured manner can also help lay the foundation for sustainable long-term development leading to a more robust and resilient health system.

Contraceptive Implant Discontinuation in Huambo and Luanda, Angola: A Qualitative Exploration of Motives [17]

The objective of this study was to understand motives for contraceptive implant discontinuation in Luanda and Huambo, Angola. We conducted 45 in-depth interviews and six focus groups amongst former and current contraceptive implant clients and family planning nurses in eight clinics. Motives for discontinuation reflect findings from other studies in similar settings, in particular the influence of adverse side effects and desire for pregnancy as motivating factors. We contextualize these findings in the Angolan setting to tease out the relationship between cultural norms of ideal family size and the perceived role of women in regards to fertility and child-bearing. We suggest that programs enter into dialog with communities to address these concerns, rather than working exclusively on improving service delivery and quality.

The Provision of Emergency Contraception in Kinshasa's Private Sector Pharmacies: Experiences of Mystery Clients [18]

The objective of this study is to explore selected pharmacies' readiness to serve women seeking emergency contraception (EC). This study used a mystery client (MC) methodology to visit 73 pharmacies in Kinshasa, Democratic Republic of Congo (DRC). Findings indicate that more than two-thirds of EC providers were knowledgeable about EC dosage, timeframe, and side effects, and 90% were deemed helpful towards novice EC users. Rare but glaring misconceptions about EC timeframe (20% of providers) and long-term side effects (4% of providers), as well as frequent stock-out (22%) and cost issues highlight priorities for programmatic improvements. As new service delivery strategies are explored to complement the uneven network of health structures in DRC, this study suggests that, given proper training and integration in FP programming, private-sector pharmacies have the potential to meet specific contraceptive needs for women living in Kinshasa.

Combating Antimicrobial Resistance with Stronger Health Systems [19]

Antimicrobial resistance (AMR) is one of the world’s most pressing and urgent global health threats —one that could erode gains against tuberculosis (TB), malaria, HIV/AIDS, and many other infectious diseases. While AMR has emerged as a critical issue at the global level, current efforts to address AMR are insufficient to curb its spread.

Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda [21]

In Gavi-eligible countries partnerships are dynamic networks of immunization actors who work together to support all stages and aspects of Gavi support. This paper describes a conceptual framework--the partnership framework--and analytic approach for evaluating the perceptions of partnerships’ value as well as the results from an application to one case in Uganda. We used a mixed-methods case study design embedded in the Gavi Full Country Evaluations to test the partnership framework on Uganda’s human papillomavirus vaccine application partnership. The partnership was not perceived to have increased the efficiency of the process, perhaps as a result of unclear or absent guidelines around roles and responsibilities. We concluded that the health and functioning of global health partnerships can be evaluated using the framework and approach presented here. Network theory and methods added value to the conceptual and analytic processes, and we recommend applying this approach to other global health partnerships to ensure that they are meeting the complex challenges they were designed to address.

Understanding the Unique Experiences, Perspectives and Sexual and Reproductive Health Needs of Very Young Adolescents: Somali Refugees in Ethiopia [22]

Kobe Refugee camp hosts roughly 39,000 refugees displaced from Somalia during the 2011–2012 Horn of Africa Crisis. Sexual and reproductive health (SRH) issues, as well as the greater issues of health and well-being for adolescents displaced from this crisis, remain largely unknown and neglected. In 2013, the Women’s Refugee Commission, Johns Hopkins University, and International Medical Corps in Ethiopia implemented qualitative and quantitative research to explore the factors and risks that impact the health of very young adolescents (VYAs), those 10–14 years of age, in this setting. This research identified several factors that were found to influence the health and well-being of VYAs in Kobe refugee camp, including newfound access to education and security, combined with gender divisions and parental communication around early SRH and puberty that remained intact from traditional Somali culture. Girls were found to face an additional risk of child marriage and early pregnancy since displacement, which significantly limited their ability to access education and achieve future aspirations.

Antimicrobial Resistance: an Online Course [23]

Antimicrobial resistance (AMR) occurs when disease-causing pathogens are able to withstand the killing or suppressing power of antimicrobial medicines. This phenomenon increases the global burden of infectious diseases and strains health systems. Parts 1 and 2 of the online course are offered at the Global Health Learning Center. Part 1

Operational Aspects of Bedaquiline Implementation in Swaziland: Report from the Field [24]

Bedaquiline (BDQ) has been recommended by the World Health Organization for the treatment of multidrug-resistant tuberculosis (MDR-TB) since 2013, but experience using the drug in high-burden, lower-income countries is limited and case studies are needed. Swaziland started using BDQ under national TB programme conditions in 2015 in four pilot sites. As of 1 December 2016, 93 patients had been initiated on BDQ, i.e., 19% of MDR-TB patients treated in the country. Swaziland has developed a systematic and efficient model for BDQ introduction in collaboration with several partners. This model is also being used to introduce other innovations and can serve as an example for other countries facing similar challenges.

HIV-Infected Adolescents Have Low Adherence to Antiretroviral Therapy: A Cross-Sectional Study in Addis Ababa, Ethiopia [25]

We interviewed 273 HIV-infected adolescents receiving antiretroviral therapy (ART) from three hospitals in Addis Ababa. The level of self-reported ART adherence among HIV-infected adolescents at the three hospitals was below the recommended threshold. Though earlier presentation of adolescents to care should be encouraged, more targeted adherence support should be planned for those who present at an early stage of their illness.

Family Planning Fact Sheet [26]

Access to safe and effective family planning is a fundamental human right, essential for achieving gender equality, eliminating extreme poverty, and reducing maternal and child deaths.

Pharmaceutical Management Considerations for Expanded Coverage of Essential Health Services and Financial Protection Programs [28]

The UN adoption of the SDGs in 2015 signaled a strong commitment of member countries to the expanded access to essential health service agenda and definitively recognized the critical role of medicines in achieving UHC.

Implementing TB Activities In Emergency Settings: South Sudan [30]

Despite challenges of operating in emergency settings, the South Sudan Challenge TB project has been able to support improvements in case notification and other TB-related indicators. This technical highlight showcases implementation strategies, results, lessons, and reflections on the way forward.

Coordinated Procurement Distribution System News [32]

Inside this issue: Enabling Proper Quantification of Essential Medicines Improved Coordination to Enhance Contraceptive Availability Establishing Common Criteria for Monitoring Supplier Performance Launching a New Pharmaceutical Logistic Information System Technical Sessions Continue to Promote Knowledge Sharing Public Sector Pharmaceutical Services Directory Released

Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan [34]

The safety, efficacy, and quality of pharmaceutical products can be highly affected by the lack of adequate controls on importation. It is therefore imperative that the importation of pharmaceutical products conforms to certain set standards. In this context, the importation of pharmaceutical products should not be treated in the same way as ordinary commodities.

Technical Report: Waste Management of Pharmaceuticals in Afghanistan [36]

Afghanistan already has a pharmaceutical product waste disposal operation, and pharmaceutical materials are reviewed for disposal and destruction, but the current operation is generally believed to have many shortfalls. Attempts at estimating the scale of the issue using total throughput volumes of pharmaceuticals have indicated no major issue on waste disposal because not enough volume of ph

Afghanistan National Medicines Policy 2014-2019 [38]

The goals of this new edition of the National Medicines Policy are to ensure the continuous development of the pharmaceutical sector and to meet the health care pharmaceutical requirements of all people living in Afghanistan, through the provision and use of safe, efficacious, high quality, cost effective, and affordable medicines and related products.

Pages

Links
[1] https://www.msh.org/resources/accredited-drug-seller-initiatives-publication-compendium-2009%E2%80%932017?page=32
[2] https://www.msh.org/resources/accredited-drug-seller-initiatives-publication-compendium-2009%E2%80%932017
[3] https://www.msh.org/resources/quality-iptp-checklist-for-facility-officers-in-charge?page=32
[4] https://www.msh.org/resources/quality-iptp-checklist-for-facility-officers-in-charge
[5] https://www.msh.org/resources/malaria-in-pregnancy-improving-access-and-use-of-quality-preventive-treatment?page=32
[6] https://www.msh.org/resources/gender-transformative-supportive-supervision-framework-and-technical-brief?page=32
[7] https://www.msh.org/resources/gender-transformative-supportive-supervision-framework-and-technical-brief
[8] https://www.msh.org/resources/leaders-who-govern-companion-guide?page=32
[9] https://www.msh.org/resources/leaders-who-govern-companion-guide
[10] https://www.msh.org/resources/pre-service-integration-guide?page=32
[11] https://www.msh.org/resources/pre-service-integration-guide
[12] https://www.msh.org/resources/network-strengthening-program-nsp?page=32
[13] https://www.msh.org/resources/network-strengthening-program-nsp
[14] https://www.msh.org/resources/ready-together-conference-program?page=32
[15] https://www.msh.org/resources/methods-used-in-prevalence-studies-of-disrespect-and-abuse-during-facility-based?page=32
[16] https://www.msh.org/resources/applying-a-new-framework-for-public-health-systems-recovery-following-emergencies-and?page=32
[17] https://www.msh.org/resources/contraceptive-implant-discontinuation-in-huambo-and-luanda-angola-a-qualitative?page=32
[18] https://www.msh.org/resources/the-provision-of-emergency-contraception-in-kinshasas-private-sector-pharmacies?page=32
[19] https://www.msh.org/resources/combating-antimicrobial-resistance-with-stronger-health-systems?page=32
[20] https://www.msh.org/resources/combating-antimicrobial-resistance-with-stronger-health-systems
[21] https://www.msh.org/resources/evaluating-global-health-partnerships-a-case-study-of-a-gavi-hpv-vaccine-application?page=32
[22] https://www.msh.org/resources/understanding-the-unique-experiences-perspectives-and-sexual-and-reproductive-health-needs?page=32
[23] https://www.msh.org/resources/antimicrobial-resistance-an-online-course?page=32
[24] https://www.msh.org/resources/operational-aspects-of-bedaquiline-implementation-in-swaziland-report-from-the-field?page=32
[25] https://www.msh.org/resources/hiv-infected-adolescents-have-low-adherence-to-antiretroviral-therapy-a-cross-sectional?page=32
[26] https://www.msh.org/resources/family-planning-fact-sheet?page=32
[27] https://www.msh.org/resources/family-planning-fact-sheet
[28] https://www.msh.org/resources/pharmaceutical-management-considerations-for-expanded-coverage-of-essential-health?page=32
[29] https://www.msh.org/resources/pharmaceutical-management-considerations-for-expanded-coverage-of-essential-health
[30] https://www.msh.org/resources/implementing-tb-activities-in-emergency-settings-south-sudan?page=32
[31] https://www.msh.org/resources/implementing-tb-activities-in-emergency-settings-south-sudan
[32] https://www.msh.org/resources/coordinated-procurement-distribution-system-news?page=32
[33] https://www.msh.org/resources/coordinated-procurement-distribution-system-news
[34] https://www.msh.org/resources/foreign-pharmaceutical-manufacturing-company-registration-guideline-for-afghanistan?page=32
[35] https://www.msh.org/resources/foreign-pharmaceutical-manufacturing-company-registration-guideline-for-afghanistan
[36] https://www.msh.org/resources/technical-report-waste-management-of-pharmaceuticals-in-afghanistan?page=32
[37] https://www.msh.org/resources/technical-report-waste-management-of-pharmaceuticals-in-afghanistan
[38] https://www.msh.org/resources/afghanistan-national-medicines-policy-2014-2019?page=32
[39] https://www.msh.org/resources/afghanistan-national-medicines-policy-2014-2019
[40] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial
[41] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=31
[42] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=28
[43] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=29
[44] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=30
[45] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=33
[46] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=34
[47] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=35
[48] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=36
[49] https://www.msh.org/resources/supporting-infection-prevention-and-control-and-optimizing-the-use-of-antimicrobial?page=56